The PSA test is one of the most familiar blood tests in men’s health, and one of the most misunderstood. Some men assume it is a simple yes or no cancer test. Others have heard it causes more harm than good. The truth sits in between, which is why major US guidelines treat PSA screening as a decision to make with your clinician rather than a routine box to check. This explainer covers what the test measures, why results can be confusing, what the main guidelines say, and the questions worth bringing to your appointment. It does not tell you whether to be screened; that is a personal decision.
What does a PSA test actually measure?
Prostate-specific antigen (PSA) is a protein made by both normal and cancerous cells of the prostate, the walnut-sized gland below the bladder. The PSA test measures how much of it is in your blood, reported in nanograms per milliliter (ng/mL). According to the National Cancer Institute (NCI), the test is used to screen men without symptoms, to help evaluate men who have prostate or urinary symptoms, and to monitor men who have already been diagnosed with prostate cancer.
The key point: PSA is a signal from the prostate, not a cancer-specific marker. Higher levels make prostate cancer more likely, but they can also come from harmless or treatable conditions.
What counts as a “normal” PSA level?
There is no single cutoff that cleanly separates normal from abnormal. The NCI notes that, in general, a level above 4.0 ng/mL is considered abnormal and may lead to a recommendation for a biopsy, but some doctors use different thresholds depending on age. In the NCI’s words, higher levels make cancer more likely, but no single level confirms it.
That is why clinicians often look at more than one number. They may consider how your PSA changes over time, your age, family history, prostate size, and other test results. The AUA guideline advises that PSA velocity, meaning how fast the number rises, should not be the only reason for further testing (Wei et al., 2023).
What can raise or lower PSA besides cancer?
The NCI lists several things that can raise PSA:
- An enlarged prostate (benign prostatic hyperplasia, or BPH), which is common with age and often causes symptoms like a weak urine stream or waking up at night to urinate
- Prostatitis, an inflammation or infection of the prostate
- A recent prostate biopsy
- Ejaculation and vigorous exercise such as cycling
- Getting older, since PSA tends to rise with age
The NCI suggests avoiding activities that may raise PSA for 2 days before testing. On the other side, the BPH medicines finasteride and dutasteride lower PSA, so doctors interpret results differently for men taking them. The CDC also notes that age, race, certain procedures and medications, an enlarged prostate, and infection can affect results (CDC).
What about supplements? Tell your clinician about everything you take. For one popular prostate herb, saw palmetto, the NCCIH reports it does not appear to affect PSA readings. More on that herb is on our saw palmetto page. No supplement has been shown to replace PSA testing or a medical evaluation.
What are the benefits and harms of PSA screening?
This is the heart of the shared decision. The USPSTF summarized the evidence in its 2018 recommendation (the Task Force notes an update is in progress). For men aged 55 to 69, it estimated that screening may prevent about 1.3 prostate cancer deaths and about 3 cases of metastatic cancer per 1,000 men screened over roughly 13 years.
The potential harms are real too:
- False positives. The NCI reports that about 6% to 7% of men have a false-positive PSA result on any given screening round, and only about 25% of men who have a biopsy because of an elevated PSA are found to have cancer.
- Biopsy complications. Biopsies can cause pain, bleeding, and infection. The USPSTF notes about 1% of biopsies lead to a hospital stay.
- Overdiagnosis. Some prostate cancers grow so slowly they would never cause problems. The USPSTF estimates 20% to 50% of screen-detected cancers may fall into this group.
- Treatment side effects. According to the USPSTF, about 1 in 5 men develop long-term urinary incontinence after surgery to remove the prostate, and about 2 in 3 develop long-term erectile dysfunction. More than half of men who have radiation develop long-term erectile problems.
How you weigh these tradeoffs depends on your values, health, and risk.
What do the major US guidelines say?
| Organization | Key points |
|---|---|
| USPSTF (2018) | Ages 55 to 69: an individual decision after discussing benefits and harms (grade C). Age 70 and older: recommends against PSA-based screening (grade D). |
| AUA/SUO (2023) | Shared decision-making based on a person’s values and preferences. Clinicians may offer a baseline PSA at ages 45 to 50, should offer screening starting at 40 to 45 for people at higher risk, and should offer regular screening every 2 to 4 years for ages 50 to 69. |
| NCI and CDC | Explain the test and its tradeoffs, and point to the USPSTF guidance on making an informed decision with a doctor. |
The U.S. Preventive Services Task Force (USPSTF) says clinicians should not screen men who do not express a preference for screening. It also highlights that Black men and men with a family history of prostate cancer have higher risk and should be informed about it, although it found insufficient evidence for a separate recommendation for these groups. The American Urological Association (AUA) and Society of Urologic Oncology guideline names Black ancestry, certain inherited (germline) gene changes, and a strong family history as reasons to start the conversation earlier. Both groups put shared decision-making at the center. The CDC notes the USPSTF does not recommend the digital rectal exam as a stand-alone screening test, while the AUA says clinicians may use it alongside PSA.
What happens if your PSA comes back high?
A single elevated result is a reason for follow-up, not a diagnosis. The NCI says a doctor may repeat the test in 6 to 8 weeks to confirm it, and the AUA guideline advises repeating a newly elevated PSA before moving on to other biomarkers, imaging, or biopsy. Depending on the results and your risk, next steps may include a digital rectal exam, additional blood or urine tests, an MRI of the prostate, or a biopsy (Wei et al., 2023, Part II). Validated risk calculators can also help you and your clinician decide whether a biopsy makes sense now.
What should you ask your doctor?
Use these questions to make the conversation concrete:
- Given my age, family history, and ancestry, is my risk average or higher than average?
- What are the likely benefits and harms of PSA screening for someone like me?
- If we test, what result would lead to more testing, and what would that involve?
- Could anything I take or do, such as BPH medicine, supplements, recent exercise, or ejaculation, affect my result?
- If my PSA is high, would we repeat it first? When would an MRI or biopsy come up?
- If cancer were found, would active monitoring be an option before treatment?
- If I decide to be screened, how often would we repeat the test, and when would we consider stopping?
It helps to bring a list of your medicines and supplements and notes on any urinary symptoms. Our page on prostate checkups and PSA questions covers what a checkup may involve, and our prostate health hub gathers related topics. If sexual side effects of treatment are a concern, you can also read about low stamina and libido after 40.
When to talk to a doctor
You do not need symptoms to start the PSA conversation. Ask about it at a routine visit if you are in the age ranges the guidelines discuss, or earlier if you are Black, carry a known inherited gene change, or have close relatives with prostate cancer. See a clinician promptly for urinary changes, blood in your urine, pain, or trouble urinating. Most urinary symptoms are not cancer, but they deserve an evaluation.
Supplements are not a substitute for this conversation. If you are curious about ingredients marketed for prostate comfort, our overview of the best-researched ingredients for prostate health explains how limited much of that evidence is, and our prostate supplement guide compares products for readers weighing options.
